Skip to main content

Table 2 Demographic and clinicopathological characteristics of participants

From: The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer

Parameters

PTC (%)

MNG (%)

Total (%)

Patients

60 (66.7)

30 (33.3)

90 (100)

Age

 < 45 years

43 (71.7)

10 (33.3)

53 (58.9)

 ≥45 years

15 (25.0)

17 (56.7)

32 (35.6)

Sex

 Male

15 (25.0)

5 (16.7)

20 (22.2)

 Female

45 (75.0)

25 (83.3)

70 (77.8)

BRAF V600E mutation

 BRAF (+)

24 (40.0)

–

–

 BRAF (−)

36 (60.0)

–

–

Tumor size

 < 2 cm

37 (61.7)

–

–

 ≥2 cm

20 (33.3)

–

–

TNM Staging

 I

46 (76.7)

–

–

 II

3 (5.0)

–

–

 III

7 (11.7)

–

–

 IV

2 (3.3)

–

–

Focality Status

 Unifocal

11 (18.3)

–

–

 Multifocality

19 (31.7)

–

–

Extracapsular invasion

 Yes

14 (23.3)

–

–

 No

45 (75.0)

–

–

LNM

 Yes

27 (45.0)

–

–

 No

32 (53.3)

–

–

Lymphovascular invasion

 Yes

8 (13.3)

–

–

 No

51 (85.0)

–

–

Variant

 Classic

50 (55.6)

–

–

 Follicular

7 (7.8)

–

–

 Hürthle cell

1 (1.1)

–

–

 Sclerosing

1 (1.1)

–

–

  1. TNM tumor node metastasis, LNM lymph node metastasis